Azzouni F Godoy A Li Y et al.

The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases.

Adv Urol. 2012530121

Steroidogenic enzymes in skin.

Eur J Dermatol. 11: 293-295Corona G Tirabassi G Santi D et al.

Sexual dysfunction in subjects treated with inhibitors of 5 a – reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.

Andrology. 5: 671-678Kiguradze T Temps WH Yarnold PR et al.

Persistent erectile dysfunction in men exposed to the 5 a -reductase inhibitors, finasteride, or dutasteride.

Peer J. 5: e3020Ganzer CA Jacobs AR Iqbal F.

Persistent Sexual, Emotional, and Cognitive Impairment Post-Finasteride: A Survey of Men Reporting Symptoms.

Am J Mens Health. 9: 222-228Chiriacò G Cauci S Mazzon G et al.

An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia.

Andrology. 4: 245-250Walf AA Kaurejo S Frye CA.

Research brief: self reports of a constellation of persistent antiandrogenic, estrogenic, physical, and psychological effects of finasteride usage among men.

Am J Mens Health. 12: 900-906

Post Finasteride Syndrome Foundation Overview [Internet].

() ()Khera M Than JK Anaissie J et al.

Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia.

Transl Androl Urol. 9: 1201-1209

Post-finasteride syndrome.

An Bras Dermatol. 95: 271-277Trüeb RM Régnier A Dutra Rezende H Gavazzoni Dias MFR

Post-finasteride syndrome: an induced delusional disorder with the potential of a mass psychogenic illness?.

Skin Appendage Disord. 5: 320-326Wessells H Roy J Bannow J et al.

PLESS Study Group. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.

Urology. 61: 579-584Nickel JC Fradet Y Boake RC et al.

Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.

CMAJ. 155: 1251-1259Mondaini N Gontero P Giubilei G et al.

Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?.

J Sex Med. 4: 1708-1712Caruso D Abbiati F Giatti S et al.

Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma.

J Steroid Biochem Mol Biol. 146: 74-79

Androgen receptor structure, function and biology: from bench to bedside.

Clin Biochem Rev. 37: 3-15

Overexpression of genes in health and sickness. A bird's eye view.

Comp Biochem Physiol B Biochem Mol Biol. 112: 1-13

Gene overexpression: uses, mechanisms, and interpretation.

Genetics. 190: 841-854Di Loreto C La Marra F Mazzon G et al.

Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia.

PloS One. 9e100237Monks DA Swift-Gallant A.

Non-neural androgen receptors affect sexual differentiation of brain and behavior.

J Neuroendocrinol. 30: e12493Chamberlain NL Driver ED Miesfeld RL.

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

Nucleic Acids Res. 22: 3181-3186Sealfon SC Chu TT.RNA microarrays DNA Methods Mol Biol. 671: 3-34

Sample size estimation while controlling false discovery rate for microarray experiments using the ssize.fdr package.

The R Journal. 1: 47-53Gentleman RC Carey VJ Bates DM et al.

Bioconductor: open software development for computational biology and bioinformatics.

Genome Biol. 5: R80

Statistical tests for differential expression in cDNA microarray experiments.

Genome Biol. 4: 210Zhou Y Zhou B Pache L et al.

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.

Nat Commun. 10: 1523Stanczyk FZ Azen CG Pike MC.

Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.

J Steroid Biochem Mol Biol. 138: 10-16Itoh F Asao H Sugamura K et al.

Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.

EMBO J. 20: 4132-4142

Neuroactive steroids.

FASEB J. 6: 2311-2322Moraga-Amaro R van Waarde A Doorduin J et al.

Sex steroid hormones and brain function: PET imaging as a tool for research.

J Neuroendocrinol. 30: e12565Finn DA Roberts AJ Long S et al.

Neurosteroid consumption has anxiolytic effects in mice.

Pharmacol Biochem Behav. 76: 451-462Khisti RT Chopde CT Jain SP.

Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test.

Pharmacol Biochem Behav. 67: 137-143Jain NS Hirani K Chopde CT.

Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats.

Neuropharmacology. 48: 627-638Rahimi-Ardabili B Pourandarjani R Habibollahi P et al.

Finasteride induced depression: a prospective study.

BMC Clin Pharmacol. 6: 7

Depression circumstantially related to the administration of finasteride for androgenetic alopecia.

J Dermatol. 29: 665-669

Neurosteroids: endogenous role in the human brain and therapeutic potentials.

Prog Brain Res. 186: 113-137

Neurosteroids’ effects and mechanisms for social, cognitive, emotional, and physical functions.

Psychoneuroendocrinology. 34: S143-S161Johnsen IK Kappler R Auernhammer CJ et al.

Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis.

Cancer Res. 69: 5784-5792Inagaki K Otsuka F Suzuki J et al.

Involvement of bone morphogenetic protein-6 in differential regulation of aldosterone production by angiotensin II and potassium in human adrenocortical cells.

Endocrinology. 147: 2681-2689Roberts AE Araki T Swanson KD et al.

Germline gain-of-function mutations in SOS1 cause Noonan syndrome.

Nat Genet. 39: 70-74Kontaridis MI Swanson KD David FS et al.

PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects.

J Biol Chem. 281: 6785-6792Bentires-Alj M Paez JG David FS et al.

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.

Cancer Res. 64: 8816-8820

Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.

Endocrinology. 117: 2505-2511LeVan TD Bloom JW Adams DG et al.

Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells.

Mol Pharmacol. 53: 135-140Perrier S Darakhshan F Hajduch E.

IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?.

FEBS Lett. 580: 6289-6294

Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology.

Crit Rev Neurobiol. 13: 45-82

Syndecans in inflammation.

FASEB J. 17: 575-591

Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells.

Eur J Pharmacol. 654: 117-121Stoecklin G Stubbs T Kedersha N et al.

MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.

EMBO J. 23: 1313-1324Lakner J Seyer C Hermsdorf T et al.

Characterization of the expression, promoter activity and molecular architecture of fibin.

BMC Biochem. 12: 26Brar BK Jonassen AK Stephanou A et al.

Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway.

J Biol Chem. 275: 8508-8514

The biology of SPARC, a protein that modulates cell-matrix interactions.

FASEB J. 8: 163-173

Emerging roles of caspase-3 in apoptosis.

Cell Death Differ. 6: 99-104Zhang G Chen Y Ju H et al.

Carbamoyl phosphate synthetase 1 deficiency diagnosed by whole exome sequencing.

J Clin Lab Anal. 32: e22241

Alterations of cortisol metabolism in human disorders.

Horm Res Paediatr. 89: 320-330Nwabuisi-Heath E Rebeck GW Ladu MJ et al.

ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro.

ASN Neuro. 6: e00134Strehlow V Heyne HO Vlaskamp DRM et al.

GRIN2A-related disorders: genotype and functional consequence predict phenotype.

Brain. 142: 80-92Tolias KF Bikoff JB Burette A et al.

The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines.

Neuron. 45: 525-538Duffney LJ Wei J Cheng J et al.

Shank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanism.

J Neurosci. 33: 15767-15778Labrie F Luu-The V Lin SX et al.

The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology.

Steroids. 62: 148-158

Yen and Jaffe's Reproductive Endocrinology.

Elsevier Health Sciences, ()Chai Z Brereton P Suzuki T et al.

17 beta-hydroxysteroid dehydrogenase type XI localizes to human steroidogenic cells.

Endocrinology. 144: 2084-2091Pierce SB Walsh T Chisholm KM et al.

Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome.

Am J Hum Genet. 87: 282-288Lachance Y Luu-The V Labrie C et al.

Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.

J Biol Chem. 267 (): 3551Takahashi K Taira T Niki T et al.

DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor.

J Biol Chem. 276: 37556-37563Fujimoto N Yeh S Kang HY et al.

Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate.

J Biol Chem. 274: 8316-8321

Daxx: death or survival protein?.

Trends Cell Biol. 16: 97-104Lin CY Tuan J Scalia P et al.

The cell cycle regulatory factor TAF1 stimulates ribosomal DNA transcription by binding to the activator UBF.

Curr Biol. 12: 2142-2146

The comings and goings of PARP-1 in response to DNA damage.

DNA Repair (Amst). 71: 177-182Hsu CL Liu JS Wu PL et al.

Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.

Mol Oncol. 8: 1575-1587Moilanen AM Poukka H Karvonen U et al.

Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription.

Mol Cell Biol. 18: 5128-5139Xu K Shimelis H Linn DE et al.

Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination.

Cancer Cell. 15: 270-282Clark EL Coulson A Dalgliesh C et al.

The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer.

Cancer Res. 68: 7938-7946Basak S Pookot D Noonan EJ et al.

Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function.

Mol Cancer Ther. 7: 3195-3202Hua Y Ying X Qian Y et al.

Physiological and pathological impact of AQP1 knockout in mice.

Biosci Rep. 39BSR20182303Amatu A Sartore-Bianchi A Siena S.

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types.

ESMO Open. 1e000023Chaldakov GN Tonchev AB Aloe L.

NGF and BDNF: from nerves to adipose tissue, from neurokines to metabokines.

Riv Psichiatr. 44: 79-87Basaria S Jasuja R Huang G et al.

Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.

J Clin Endocrinol Metab. 101: 4669-4680

The role of TGF-β superfamily signaling in neurological disorders.

Acta Biochim Biophys Sin (Shanghai). 50: 106-120